SlideShare a Scribd company logo
1 of 16
Molecular Mechanism of Multi Drug
Resistance (MDR)
Geetanjali Baruah
 In 2015, an estimated 4,80,000 people
worldwide developed MDR-TB
 An additional 1,00,000 people with rifampicin-
resistant TB were also newly eligible for MDR-
TB treatment
 India, China, and the Russian Federation
accounted for 45% of the 5,80,000 cases
 It is estimated that about 9.5% of these cases
were XDR-TB (WHO, March 2017)
 In Europe 25,000 people die each year due to
MDR bacterial infections, costs €1.5 billion
annually
The concern is real
The concern is real
The history and benefits
Reasons behind the crisis
 Overuse
 Inappropriate Prescribing
 Extensive agricultural use
 Availability of few new antibiotics
 Regulatory barriers
Multiple Drug resistance (MDR): MDR was defined as
acquired non-susceptibility to at least one agent in three or
more antimicrobial categories
Extensive Drug resistance (XDR): XDR was defined as
non-susceptibility to at least one agent in all but two or
fewer antimicrobial categories (i.e. bacterial isolates remain
susceptible to only one or two categories)
Pan-drug resistant (PAN) : PDR was defined as non-
susceptibility to all agents in all antimicrobial categories
How an antibiotic works
Types:
Bactericidal: Bactericidal antibiotics kill bacteria
e.g. Beta-lactam antibiotics (penicillin
derivatives), cephalosporins, monobactams,
carbapenems and vancomycin
Bacteriostatic: Bacteriostatic antibiotics slow
their growth or reproduction
e.g. Chloramphenicol, clindamycin, and linezolid
Intrinsic resistance in bacteria
Examples:
oTriclosan
- Unable to inhibit gram-negative
Pseudomonas
Reason: carries an insensitive allele
of fabI (encodes an additional enoyl-
ACP reductase enzyme)
oDaptomycin
- Active against G+ not G-
Reason: G- bacteria have low anionic
phospholipids in cytoplasmic membrane
(Blair et al., Nature reviews, 2015)
E. coli genes responsible:
thioredoxin (TrxA), thioredoxin
reductase (TrxB), FabI, RecQ, SapC,
DacA
if inhibited, can greatly promote the activity
of existing drugs
Understanding about genetic basis
of intrinsic bacterial resistance
and the spectrum of activity of an
antibiotic are key to new
combinations with improved or
expanded activity against target
species
3 Basic ways of acquired resistance:
minimize the intracellular concentration of
antibiotic by poor penetration or efflux
Modification of target by mutation or post-
translational modification
Inactivation of antibiotic by hydrolysis or
modification
Mode of action & acquired resistance
1. Inhibition of Cell Wall Synthesis
Beta-Lactams: Inhibition of peptidoglycan synthesis
Resistance: fails to cross membrane, fails to bind to altered PBP’s &
hydrolysis by beta-lactamases
2. Inhibition of Protein Synthesis
30S Ribosome site:
Tetracyclines: Block tRNA binding to 30S ribosome-mRNA complex (b-
static)
Resistance : decreased penetration, active efflux , protection of 30S
ribosome
50S Ribosome site:
Chloramphenicol: Binds peptidyl transferase of 50S ribosome, blocks
peptide elongation
Resistance: plasmid-encoded chloramphenicol transferase, altered
outer membrane
Mode of action & acquired resistance
3. Alteration of Cell Membranes
Bacitracin: Disrupt cytoplasmic membranes
Resistance: inability to penetrate outer membrane
4. Inhibition of Nucleic Acid Synthesis
DNA :
Quinolones: Inhibit DNA gyrases or topoisomerases; bind to alpha subunit
Resistance: alteration of alpha subunit of DNA gyrase, decreased uptake by
alteration of porins
RNA:
Rifampin: Binds to DNA-dependent RNA polymerase inhibiting initiation &
Rifabutin of RNA synthesis
Resistance: altered beta subunit of RNA polymerase , intrinsic resistance
(decreased uptake)
5. Antimetabolite Activity
Sulfonamides: Compete with p-aminobenzoic acid (PABA) preventing
synthesis of folic acid
Resistance: permeability barriers
Mode of action & acquired resistance
Some recent facts
Prevention of access to target
Reduced permeability
- Hydrophilic antibiotics diffusing through outer-membrane porin proteins
- Major porins OmpF and OmpC of E. coli, previous evidence said drug-
binding sites present within which was proven wrong
-reducing the permeability of the OM by the downregulation or by replaceing
with more-selective channels
Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp., reductions
in porin expression significantly contribute to resistance to newer drugs
Increased efflux
-When overexpressed, efflux pumps confers high levels of resistance
-Some efflux pumps have narrow substrate specificity (for example, the Tet
pumps), but many transport a wide range of structurally dissimilar substrates
and are known as multidrug resistance (MDR) efflux pumps
Recent understandings on acquired resistance
(Blair et al., Nature reviews, 2015)
Changes by mutation
modification through the
formation of ‘mosaic’ genes. E.g.
penicillin resistance in S.
pneumoniae, by mosaic
penicillin-binding protein
(encodes penicillin-insensitive
enzymes), arisen by
recombination with
Streptococcus mitis
Modification of targets
qnr families of quinolone
resistance genes encode
pentapeptide repeat proteins
(PRPs), which bind to and
protect topoisomerase IV and
DNA gyrase from the lethal
action of quinolones
Direct modification of antibiotics
Inactivation of antibiotics by
hydrolysis
The early β lactamases, which were‑
active against first-generation
β lactams, were followed by extended-‑
spectrum β lactamases (ESBLs)‑
Inactivation of antibiotic by
transfer of a chemical group
-addition of chemical groups to
vulnerable sites on the antibiotic
molecule by bacterial enzymes causes
antibiotic resistance by preventing the
antibiotic from binding to its target
protein as a result of steric hindrance
-Aminoglycoside antibiotics are
particularly susceptible
Cell Reports| 2017
On the basis of RNA seq and Tn seq data Jensen et al. suggested
nutrient and antibiotic stresses respectively lead to coordinated
and uncoordinated responses. Network models are thus key to
understanding cellular responses, thereby aiding in predicting bacterial
behavior
THANK YOU

More Related Content

What's hot

Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
-
 
Carbapenam Resistant Klebsiella Pneumoniae
Carbapenam Resistant Klebsiella PneumoniaeCarbapenam Resistant Klebsiella Pneumoniae
Carbapenam Resistant Klebsiella Pneumoniae
Doctors Republic
 

What's hot (20)

Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
 
Mechanism of development for drug resistance
Mechanism of development for drug resistanceMechanism of development for drug resistance
Mechanism of development for drug resistance
 
Mechanism Of Resistance Of Antibiotics
Mechanism Of Resistance Of AntibioticsMechanism Of Resistance Of Antibiotics
Mechanism Of Resistance Of Antibiotics
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
Antimicrobial drug resistance
Antimicrobial drug resistanceAntimicrobial drug resistance
Antimicrobial drug resistance
 
Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
 
Antibiotic resistance mechanism
Antibiotic resistance mechanism Antibiotic resistance mechanism
Antibiotic resistance mechanism
 
Antibiotics and its mechanism of action
Antibiotics and its mechanism of actionAntibiotics and its mechanism of action
Antibiotics and its mechanism of action
 
ANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCEANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCE
 
Efflux pumps
Efflux pumpsEfflux pumps
Efflux pumps
 
Antibiotics resistance
Antibiotics resistanceAntibiotics resistance
Antibiotics resistance
 
Carbapenam Resistant Klebsiella Pneumoniae
Carbapenam Resistant Klebsiella PneumoniaeCarbapenam Resistant Klebsiella Pneumoniae
Carbapenam Resistant Klebsiella Pneumoniae
 
Drug resistance
Drug resistanceDrug resistance
Drug resistance
 
Multi drug resistanse
Multi drug resistanseMulti drug resistanse
Multi drug resistanse
 
Antimicrobial resistance and Biofilm
Antimicrobial resistance and Biofilm Antimicrobial resistance and Biofilm
Antimicrobial resistance and Biofilm
 
Antimicrobial resistance mechanism
Antimicrobial resistance mechanismAntimicrobial resistance mechanism
Antimicrobial resistance mechanism
 
Multidrug resistance in Microbes
Multidrug resistance in MicrobesMultidrug resistance in Microbes
Multidrug resistance in Microbes
 
Efflax pumps
Efflax pumpsEfflax pumps
Efflax pumps
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 

Similar to Molecular mechanism of multi drug resistance

Antibiotic resistance in bacteria 1
Antibiotic resistance in bacteria 1Antibiotic resistance in bacteria 1
Antibiotic resistance in bacteria 1
anusil
 

Similar to Molecular mechanism of multi drug resistance (20)

antibacterial drug resistance
antibacterial drug resistance antibacterial drug resistance
antibacterial drug resistance
 
Drug delivery strategies for combating multiple drug resistance
Drug delivery strategies for combating multiple drug resistanceDrug delivery strategies for combating multiple drug resistance
Drug delivery strategies for combating multiple drug resistance
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
pathway presentation.pptx
pathway presentation.pptxpathway presentation.pptx
pathway presentation.pptx
 
Antimicrobials
AntimicrobialsAntimicrobials
Antimicrobials
 
Antimicrobials.pptx
Antimicrobials.pptxAntimicrobials.pptx
Antimicrobials.pptx
 
Role of pharmacists in combating drug resistatnce
Role of pharmacists in combating drug resistatnceRole of pharmacists in combating drug resistatnce
Role of pharmacists in combating drug resistatnce
 
Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics)
Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics) Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics)
Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics)
 
Bacterial drug resistance
Bacterial drug resistanceBacterial drug resistance
Bacterial drug resistance
 
Bacterial drug resistance
Bacterial drug resistanceBacterial drug resistance
Bacterial drug resistance
 
Management of antibiotic resistance upload
Management of antibiotic resistance uploadManagement of antibiotic resistance upload
Management of antibiotic resistance upload
 
xdr final.pptx
xdr final.pptxxdr final.pptx
xdr final.pptx
 
Antibiotic use 09 revised.ppt
Antibiotic use 09 revised.pptAntibiotic use 09 revised.ppt
Antibiotic use 09 revised.ppt
 
Antibiotic resistance in bacteria 1
Antibiotic resistance in bacteria 1Antibiotic resistance in bacteria 1
Antibiotic resistance in bacteria 1
 
MDR-TB
MDR-TBMDR-TB
MDR-TB
 
Combating drug resistance
Combating drug resistanceCombating drug resistance
Combating drug resistance
 
Antibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad SahAntibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad Sah
 
Antibiotics ppt
Antibiotics pptAntibiotics ppt
Antibiotics ppt
 
Antibiotic drug resistnc and susceptibility
Antibiotic drug resistnc and susceptibilityAntibiotic drug resistnc and susceptibility
Antibiotic drug resistnc and susceptibility
 
Mecanismos de resistencia del Streptococcus pneumoniae
Mecanismos de resistencia del Streptococcus pneumoniaeMecanismos de resistencia del Streptococcus pneumoniae
Mecanismos de resistencia del Streptococcus pneumoniae
 

Recently uploaded

DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSS
LeenakshiTyagi
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
PirithiRaju
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Sérgio Sacani
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Sérgio Sacani
 

Recently uploaded (20)

Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Chromatin Structure | EUCHROMATIN | HETEROCHROMATIN
Chromatin Structure | EUCHROMATIN | HETEROCHROMATINChromatin Structure | EUCHROMATIN | HETEROCHROMATIN
Chromatin Structure | EUCHROMATIN | HETEROCHROMATIN
 
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdf
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSS
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
 
fundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomologyfundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomology
 
Chemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfChemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdf
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
Botany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questionsBotany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questions
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
 
Pulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceuticsPulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceutics
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 

Molecular mechanism of multi drug resistance

  • 1. Molecular Mechanism of Multi Drug Resistance (MDR) Geetanjali Baruah
  • 2.  In 2015, an estimated 4,80,000 people worldwide developed MDR-TB  An additional 1,00,000 people with rifampicin- resistant TB were also newly eligible for MDR- TB treatment  India, China, and the Russian Federation accounted for 45% of the 5,80,000 cases  It is estimated that about 9.5% of these cases were XDR-TB (WHO, March 2017)  In Europe 25,000 people die each year due to MDR bacterial infections, costs €1.5 billion annually The concern is real
  • 4. The history and benefits
  • 5. Reasons behind the crisis  Overuse  Inappropriate Prescribing  Extensive agricultural use  Availability of few new antibiotics  Regulatory barriers Multiple Drug resistance (MDR): MDR was defined as acquired non-susceptibility to at least one agent in three or more antimicrobial categories Extensive Drug resistance (XDR): XDR was defined as non-susceptibility to at least one agent in all but two or fewer antimicrobial categories (i.e. bacterial isolates remain susceptible to only one or two categories) Pan-drug resistant (PAN) : PDR was defined as non- susceptibility to all agents in all antimicrobial categories
  • 6. How an antibiotic works Types: Bactericidal: Bactericidal antibiotics kill bacteria e.g. Beta-lactam antibiotics (penicillin derivatives), cephalosporins, monobactams, carbapenems and vancomycin Bacteriostatic: Bacteriostatic antibiotics slow their growth or reproduction e.g. Chloramphenicol, clindamycin, and linezolid
  • 7. Intrinsic resistance in bacteria Examples: oTriclosan - Unable to inhibit gram-negative Pseudomonas Reason: carries an insensitive allele of fabI (encodes an additional enoyl- ACP reductase enzyme) oDaptomycin - Active against G+ not G- Reason: G- bacteria have low anionic phospholipids in cytoplasmic membrane (Blair et al., Nature reviews, 2015) E. coli genes responsible: thioredoxin (TrxA), thioredoxin reductase (TrxB), FabI, RecQ, SapC, DacA if inhibited, can greatly promote the activity of existing drugs Understanding about genetic basis of intrinsic bacterial resistance and the spectrum of activity of an antibiotic are key to new combinations with improved or expanded activity against target species
  • 8. 3 Basic ways of acquired resistance: minimize the intracellular concentration of antibiotic by poor penetration or efflux Modification of target by mutation or post- translational modification Inactivation of antibiotic by hydrolysis or modification Mode of action & acquired resistance
  • 9. 1. Inhibition of Cell Wall Synthesis Beta-Lactams: Inhibition of peptidoglycan synthesis Resistance: fails to cross membrane, fails to bind to altered PBP’s & hydrolysis by beta-lactamases 2. Inhibition of Protein Synthesis 30S Ribosome site: Tetracyclines: Block tRNA binding to 30S ribosome-mRNA complex (b- static) Resistance : decreased penetration, active efflux , protection of 30S ribosome 50S Ribosome site: Chloramphenicol: Binds peptidyl transferase of 50S ribosome, blocks peptide elongation Resistance: plasmid-encoded chloramphenicol transferase, altered outer membrane Mode of action & acquired resistance
  • 10. 3. Alteration of Cell Membranes Bacitracin: Disrupt cytoplasmic membranes Resistance: inability to penetrate outer membrane 4. Inhibition of Nucleic Acid Synthesis DNA : Quinolones: Inhibit DNA gyrases or topoisomerases; bind to alpha subunit Resistance: alteration of alpha subunit of DNA gyrase, decreased uptake by alteration of porins RNA: Rifampin: Binds to DNA-dependent RNA polymerase inhibiting initiation & Rifabutin of RNA synthesis Resistance: altered beta subunit of RNA polymerase , intrinsic resistance (decreased uptake) 5. Antimetabolite Activity Sulfonamides: Compete with p-aminobenzoic acid (PABA) preventing synthesis of folic acid Resistance: permeability barriers Mode of action & acquired resistance
  • 11. Some recent facts Prevention of access to target Reduced permeability - Hydrophilic antibiotics diffusing through outer-membrane porin proteins - Major porins OmpF and OmpC of E. coli, previous evidence said drug- binding sites present within which was proven wrong -reducing the permeability of the OM by the downregulation or by replaceing with more-selective channels Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp., reductions in porin expression significantly contribute to resistance to newer drugs Increased efflux -When overexpressed, efflux pumps confers high levels of resistance -Some efflux pumps have narrow substrate specificity (for example, the Tet pumps), but many transport a wide range of structurally dissimilar substrates and are known as multidrug resistance (MDR) efflux pumps
  • 12. Recent understandings on acquired resistance (Blair et al., Nature reviews, 2015)
  • 13. Changes by mutation modification through the formation of ‘mosaic’ genes. E.g. penicillin resistance in S. pneumoniae, by mosaic penicillin-binding protein (encodes penicillin-insensitive enzymes), arisen by recombination with Streptococcus mitis Modification of targets qnr families of quinolone resistance genes encode pentapeptide repeat proteins (PRPs), which bind to and protect topoisomerase IV and DNA gyrase from the lethal action of quinolones
  • 14. Direct modification of antibiotics Inactivation of antibiotics by hydrolysis The early β lactamases, which were‑ active against first-generation β lactams, were followed by extended-‑ spectrum β lactamases (ESBLs)‑ Inactivation of antibiotic by transfer of a chemical group -addition of chemical groups to vulnerable sites on the antibiotic molecule by bacterial enzymes causes antibiotic resistance by preventing the antibiotic from binding to its target protein as a result of steric hindrance -Aminoglycoside antibiotics are particularly susceptible
  • 15. Cell Reports| 2017 On the basis of RNA seq and Tn seq data Jensen et al. suggested nutrient and antibiotic stresses respectively lead to coordinated and uncoordinated responses. Network models are thus key to understanding cellular responses, thereby aiding in predicting bacterial behavior

Editor's Notes

  1. These are the 5 basic mechanism of action